NEW PROTOCOL SUBMISSIONS

New Requirement: Medicare Coverage Analysis (MCA)
Medicare Coverage Analysis (MCA) is now required for all new clinical trials in which any tests, procedures and interventions performed on study subjects are invoiced to a third party payer. PHRC activation of a protocol is contingent upon completion of the MCA by the Partners Clinical Research Office (PCRO). Learn more...

Important Data for NIH Funded Studies
Information on gender, race and ethnicity of patients seen at BWH and MGH.

Submit Forms/Documents Electronically to the PHRC

When you are done completing your form(s), click here to learn how to submit your completed forms electronically (PHS intranet link).

For Assistance with Submission Preparation, Study Design, Utilization of Research Study Coordinators, and Facility to Evaluate Patients, etc, contact:

BWH Center for Clinical Investigation
(CCI)
MGH Clinical Research Program (CRP)

Click on a form name in the table below to open the individual form and save it to your computer to complete.

New Protocol Submission Forms
For studies involving oncology / cancer research and/or DFCI principal investigators, co-investigators or any other DFCI resource, see the oncology guidance before completing any of the following forms.

Submission Instructions and Checklist
6/08

Instructions and checklist for the submission of a new research protocol for PHRC review.
Human Subject Intervention / Interaction Forms

Application Form
8/08

 

For research involving an intervention or interaction with human subjects. In some cases an Expedited Application Form may be used, or for research limited to Health/Medical Records and Human Material/Tissue, see limited research application forms below.

 

Expedited Application Form
7/08

For research limited to blood collection; prospective collection of data/samples by noninvasive means; collection of data through noninvasive procedures routinely employed in clinical practice; collection of data through audiovisual recordings made for research purposes; research employing surveys, interviews, focus groups, evaluation or QA methodologies. NOTE: A full application may be required at the discretion of the PHRC chair reviewing the protocol.

Sponsor/Funding Information
4/02

 

To be included with a PHRC submission when a research study has more than one sponsor.
Investigator Financial Disclosure
2/08

Principal investigators and co-investigators must complete this form and submit to the IRB in conjunction with the Application form when the research involves ANY of the following: (1) for-profit sponsor or funding source; (2) a marketed drug, device, or other technology, or a drug, device, or other technology in development; or (3) a new technology, software or therapeutic approach.

 

Site Responsible Investigator
8/08

To be included with a PHRC submission when a research study involves multiple Partners performance sites, e.g., BWH and MGH, complete the site-responsible investigator form for all sites except the overall PI's site.


Co-Investigator/ Study Staff Certification
8/07

To be included with a PHRC submission for each Co-Investigator and study staff member. Only one individual in addition to the PI should be designated as the contact person.

If non-BWH/non-MGH employees will perform institutionally designated research activities or exercise institutionally delegated authority or responsibility for research, please see the policy "Non-BWH/MGH Employees As Co-Investigators/Study Staff."

HSPH Site Responsible Investigator
6/06

To be included with a PHRC submission when a research study involves Harvard School of Public Health (HSPH) as a performance site.

 

Protocol Summary
6/05

To be included with a PHRC submission unless noted otherwise in submission instructions. Summary document describes protocol and investigator's plan for recruitment and enrollment of subjects. Includes important regulatory information needed for IRB review. Refer to documents Prescreening and Recruitment Guidelines for acceptable methods of recruitment. Sample recruitment letters are available.


Schema Instructions
3/98

 

To be included with a PHRC submission when the research involves multiple groups, treatment arms, or randomization.
Detailed Protocol Instructions
3/02

Instructions for investigators who are writing their own protocol for use when there is no sponsor initiated protocol or cooperative group protocol.


Ancillary Committee/Specialized Review Forms:
These forms must be submitted with the application form when applicable.
Children
8/08


For research enrolling children as research subjects.

Individuals with Impaired Decision-making
6/05

For research involving adult subjects with impaired decision-making capacity who cannot give informed consent and for whom consent to participate in research will be obtained from a legally authorized representative as determined by state or local law.
Neonates in Research
11/05

For research involving neonates of uncertain viability and/or nonviable neonates.
Pregnant Women/Fetuses
6/05


For research involving pregnant women and human fetuses.

Wards of the State
8/08

 

For research enrolling children as research subjects who are wards of the State.

Medical Devices
6/07



Non-Hospital Inventory FDA-Approved Devices
8/08

For research involving a medical device that is being investigated or used as a comparator, or for non-FDA approved medical devices that are being used to study human physiology, complete the Medical Device form. A separate form should be completed for each medical device being investigated or used.

For research involving a non-hospital inventory FDA-approved medical devices provided by the sponsor or others that is used for research-related ancillary tests, procedures, or monitoring in accordance with the device’s FDA-approved labeling, complete the Non-Hospital Inventory FDA-Approved Devices form. A separate form should be completed for each non-hospital inventory FDA-approved medical device being provided.

 

Drugs/Biologics
8/05

For research evaluating or using FDA-approved or investigational drugs or biologics. A separate form should be completed for each drug or biologic being evaluated or used. Do not complete this form for supportive care drugs.

 

Nursing (Inpatient Studies)
3/98

For research involving inpatients.

 

Radiation Exposure
3/98

For research involving research related exposure to x-rays or radiation.
Nonionizing Radiation
11/01

For research involving research related exposure to nonionizing radiation: ultrasound, MRI, lasers, or ultra-violet radiation.

 

Waiver of Informed Consent and
Authorization for Research

2/03

Form used to request waiver of informed consent and authorization from subjects. See PHRC Policy on Waivers of Informed Consent and Authorization.
Research Limited to Health/Medical Records and Human Material/Tissue Application Forms
Excess Human Material
12/06

For research limited to the use of human material/tissue collected as part of the patient's clinical care.

 

Health/Medical Records
12/06

 

For research limited to the use of health/medical records only. Replaces the Medical Records form.
Research Data Repository
11/03

For establishment of a data repository of identifiable health information derived from patient medical records, other hospital records, or practice-based patient health information to conduct research and/or quality improvement activities. Replaces the Research-Related Patient Database form.

 

Secondary Use of Research Samples/Data
4/03

For research limited to the secondary use of human samples or data. Secondary use is the use of previously collected samples and/or data for a new research project.

 

Tissue or Sample Repository
12/05
For research projects which bank or store human material/tissue for future research uses. TISSUE is defined as any specimen/sample obtained from patients (or human research subjects), for example, fixed, frozen or fresh pathology or autopsy specimens, any blood, urine, saliva, semen, breast milk or other biological material, any purified DNA, RNA, proteins, cell lines or clones. See Policies & Guidance on Tissue Uses and Tissue Banking.